-
An article by Megan Murphy:
``Biotechnology companies that have staked lucrative claims to parts of the human genetic sequence were on Thursday dealt a blow by the High Court in a decision that may set a higher threshold for intellectual property protection.
``In the first UK case to examine how `bioinformatics' – the use of powerful computer programmes to work out the relationship between the human genome and the design of new drugs – affects patentability, the court revoked a patent held by Human Genome Sciences on a disease-linked protein known as `neutrokine-alpha.'''
Full story:
http://www.ft.com/cms/s/0/c2649894-5f54-11dd-91c0-000077b07658.html
Discussion forums: Financial Times: Biotech companies hit by patent ruling
Expanded view | Monitor forum | Save place
Start a new thread:
You have to be logged in to post a reply.